Literature DB >> 2574621

Anti-Thy-1 immunotoxin, OX7-saporin, destroys cerebellar Purkinje cells after intraventricular injection in rats.

T L Davis1, R G Wiley.   

Abstract

Thy-1 is an abundant surface glycoprotein of rat neurons. OX7 is a monoclonal antibody with high affinity for Thy-1. This study sought to determine if intraventricularly administered OX7 could serve as a carrier to deliver cytotoxin to neurons, thus destroying those neurons. Saporin (Sap), a ribosome-inactivating protein was disulfide-coupled to OX7 (OX7-Sap). OX7-Sap, OX7, saporin alone, pooled non-immune mouse IgG, and an irrelevant immunotoxin, RFT-1-Sap, were injected into the lateral ventricles of anesthetized adult rats. Animals were observed for 1-8 days. OX7-Sap-injected animals developed coarse head tremor and gait/truncal ataxia in a dose-dependent manner beginning 24 h or more after injection. All control animals remained healthy. After OX7 or OX7-Sap injection, immunoperoxidase staining for mouse IgG was most intense and specific in the molecular and Purkinje cell layers of the cerebellar cortex. Cresyl violet staining demonstrated destruction of the Purkinje cell layer in the OX7-Sap-treated animals but not in controls. These results indicate that intraventricular injections of OX7 can be used to deliver biologically active moieties to the Purkinje cells. This approach may prove useful in analysis of Purkinje cell function and as a model of cerebellar degeneration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574621     DOI: 10.1016/0006-8993(89)91360-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Thy1 associates with the cation channel subunit HCN4 in adult rat retina.

Authors:  Gloria J Partida; Tyler W Stradleigh; Genki Ogata; Iv Godzdanker; Andrew T Ishida
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-26       Impact factor: 4.799

2.  Purkinje cell loss by OX7-saporin impairs excitatory and inhibitory eyeblink conditioning.

Authors:  Brian C Nolan; John H Freeman
Journal:  Behav Neurosci       Date:  2005-02       Impact factor: 1.912

3.  Intraneural OX7-saporin for neuroma-in-continuity in a rat model.

Authors:  Andreas F Mavrogenis; Kitty Pavlakis; Anna Stamatoukou; Panayiotis J Papagelopoulos; Stamatis Theoharis; Zijie Zetahang; Panayotis N Soucacos; Aristides B Zoubos
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-04-27

4.  Purkinje cell loss by OX7-saporin impairs acquisition and extinction of eyeblink conditioning.

Authors:  Brian C Nolan; John H Freeman
Journal:  Learn Mem       Date:  2006 May-Jun       Impact factor: 2.460

5.  Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia.

Authors:  D Giulian; L J Haverkamp; J H Yu; W Karshin; D Tom; J Li; J Kirkpatrick; L M Kuo; A E Roher
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

6.  Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics.

Authors:  Kenneth E Hill; Susan A Clawson; John W Rose; Noel G Carlson; John E Greenlee
Journal:  J Neuroinflammation       Date:  2009-10-29       Impact factor: 8.322

7.  Diphtheria toxin mutant selectively kills cerebellar Purkinje neurons.

Authors:  C J Riedel; K M Muraszko; R J Youle
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

8.  192 IgG-saporin. 2. Neuropathology in the rat brain.

Authors:  A A Book; R G Wiley; J B Schweitzer
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Differential phosphorylation in vivo of cytoplasmic dynein associated with anterogradely moving organelles.

Authors:  J F Dillman; K K Pfister
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

Review 10.  Saporin from Saponaria officinalis as a Tool for Experimental Research, Modeling, and Therapy in Neuroscience.

Authors:  Alexey P Bolshakov; Mikhail Yu Stepanichev; Yulia V Dobryakova; Yulia S Spivak; Vladimir A Markevich
Journal:  Toxins (Basel)       Date:  2020-08-25       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.